Logo image of AGLX.OL

AGILYX ASA (AGLX.OL) Stock Fundamental Analysis

OSL:AGLX - Euronext Oslo - NO0010872468 - Common Stock - Currency: NOK

28.35  +0.25 (+0.89%)

Fundamental Rating

5

AGLX gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 41 industry peers in the Commercial Services & Supplies industry. AGLX has a great financial health rating, but its profitability evaluates not so good. AGLX has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year AGLX was profitable.
AGLX had a negative operating cash flow in the past year.
AGLX had negative earnings in 4 of the past 5 years.
AGLX had a negative operating cash flow in each of the past 5 years.
AGLX.OL Yearly Net Income VS EBIT VS OCF VS FCFAGLX.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 0 20M -20M 40M 60M 80M

1.2 Ratios

AGLX has a Return On Assets of 72.71%. This is amongst the best in the industry. AGLX outperforms 97.56% of its industry peers.
AGLX has a Return On Equity of 76.52%. This is amongst the best in the industry. AGLX outperforms 97.56% of its industry peers.
Industry RankSector Rank
ROA 72.71%
ROE 76.52%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
AGLX.OL Yearly ROA, ROE, ROICAGLX.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 -20 -40 -60 -80 -100

1.3 Margins

The Profit Margin of AGLX (1355.78%) is better than 100.00% of its industry peers.
Looking at the Gross Margin, with a value of 4.51%, AGLX is doing worse than 80.49% of the companies in the same industry.
AGLX's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM N/A
PM (TTM) 1355.78%
GM 4.51%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-38.6%
GM growth 5YN/A
AGLX.OL Yearly Profit, Operating, Gross MarginsAGLX.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 0 500 1K 1.5K

More info and screens

8

2. Health

2.1 Basic Checks

AGLX does not have a ROIC to compare to the WACC, probably because it is not profitable.
There is no outstanding debt for AGLX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
AGLX.OL Yearly Shares OutstandingAGLX.OL Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 20M 40M 60M
AGLX.OL Yearly Total Debt VS Total AssetsAGLX.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 10M 20M 30M 40M

2.2 Solvency

AGLX has an Altman-Z score of 31.78. This indicates that AGLX is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of AGLX (31.78) is better than 100.00% of its industry peers.
AGLX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 31.78
ROIC/WACCN/A
WACC8.54%
AGLX.OL Yearly LT Debt VS Equity VS FCFAGLX.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 0 10M -10M 20M -20M 30M

2.3 Liquidity

A Current Ratio of 3.84 indicates that AGLX has no problem at all paying its short term obligations.
AGLX has a Current ratio of 3.84. This is amongst the best in the industry. AGLX outperforms 95.12% of its industry peers.
AGLX has a Quick Ratio of 3.84. This indicates that AGLX is financially healthy and has no problem in meeting its short term obligations.
AGLX has a better Quick ratio (3.84) than 95.12% of its industry peers.
Industry RankSector Rank
Current Ratio 3.84
Quick Ratio 3.84
AGLX.OL Yearly Current Assets VS Current LiabilitesAGLX.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 10M 20M 30M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 441.41% over the past year.
Looking at the last year, AGLX shows a very negative growth in Revenue. The Revenue has decreased by -62.18% in the last year.
The Revenue has been growing by 10.78% on average over the past years. This is quite good.
EPS 1Y (TTM)441.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%7.77%
Revenue 1Y (TTM)-62.18%
Revenue growth 3Y10.78%
Revenue growth 5YN/A
Sales Q2Q%-94.49%

3.2 Future

AGLX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 31.22% yearly.
The Revenue is expected to decrease by -2.13% on average over the next years.
EPS Next Y17.54%
EPS Next 2Y17.11%
EPS Next 3Y20.2%
EPS Next 5Y31.22%
Revenue Next Year-25.15%
Revenue Next 2Y54.65%
Revenue Next 3Y-18.42%
Revenue Next 5Y-2.13%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
AGLX.OL Yearly Revenue VS EstimatesAGLX.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 10M 20M 30M
AGLX.OL Yearly EPS VS EstimatesAGLX.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 0 0.1 -0.1 0.2 -0.2

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 2.81, which indicates a rather cheap valuation of AGLX.
Based on the Price/Earnings ratio, AGLX is valued cheaply inside the industry as 97.56% of the companies are valued more expensively.
AGLX is valuated cheaply when we compare the Price/Earnings ratio to 26.25, which is the current average of the S&P500 Index.
The Forward Price/Earnings Ratio is negative for AGLX. No positive earnings are expected for the next year.
Industry RankSector Rank
PE 2.81
Fwd PE N/A
AGLX.OL Price Earnings VS Forward Price EarningsAGLX.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AGLX.OL Per share dataAGLX.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

AGLX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as AGLX's earnings are expected to grow with 20.20% in the coming years.
PEG (NY)0.16
PEG (5Y)N/A
EPS Next 2Y17.11%
EPS Next 3Y20.2%

More info and screens

0

5. Dividend

5.1 Amount

AGLX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AGILYX ASA

OSL:AGLX (5/30/2025, 7:00:00 PM)

28.35

+0.25 (+0.89%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)04-24 2025-04-24/amc
Earnings (Next)08-21 2025-08-21
Inst Owners28.67%
Inst Owner ChangeN/A
Ins Owners0.44%
Ins Owner ChangeN/A
Market Cap3.13B
Analysts84.44
Price Target38.25 (34.92%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.66%
PT rev (3m)-0.66%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)6%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.59%
Valuation
Industry RankSector Rank
PE 2.81
Fwd PE N/A
P/S 48.49
P/FCF N/A
P/OCF N/A
P/B 2.74
P/tB 2.81
EV/EBITDA N/A
EPS(TTM)10.08
EY35.56%
EPS(NY)-1.49
Fwd EYN/A
FCF(TTM)-1.33
FCFYN/A
OCF(TTM)-1.07
OCFYN/A
SpS0.58
BVpS10.36
TBVpS10.1
PEG (NY)0.16
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 72.71%
ROE 76.52%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 1355.78%
GM 4.51%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-38.6%
GM growth 5YN/A
F-Score4
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 290.8%
Cap/Sales 43.86%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.84
Quick Ratio 3.84
Altman-Z 31.78
F-Score4
WACC8.54%
ROIC/WACCN/A
Cap/Depr(3y)399.65%
Cap/Depr(5y)N/A
Cap/Sales(3y)51.53%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)441.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%7.77%
EPS Next Y17.54%
EPS Next 2Y17.11%
EPS Next 3Y20.2%
EPS Next 5Y31.22%
Revenue 1Y (TTM)-62.18%
Revenue growth 3Y10.78%
Revenue growth 5YN/A
Sales Q2Q%-94.49%
Revenue Next Year-25.15%
Revenue Next 2Y54.65%
Revenue Next 3Y-18.42%
Revenue Next 5Y-2.13%
EBIT growth 1Y-1.95%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year53.52%
EBIT Next 3Y23.94%
EBIT Next 5Y36.27%
FCF growth 1Y-3.11%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y7.27%
OCF growth 3YN/A
OCF growth 5YN/A